Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | genetic association 0.25 (overall 0.15) | 0.25 |
| cell type Human Protein Atlas | cell type enhanced, including oligodendrocyte progenitor cells; strongest in peritubular myoid cells | 0.75 |
| chemistry Open Targets | hard to drug | 0.00 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | no papers tie it to Parkinson's yet | 1.00 |
| pathways Reactome | in no curated pathway | 0.00 |
No case: the score is under the bar. Receipt 2181
Sealed predictions
- PDZRN4 in dopamine neurons, braak+0.69 (p 0.042) → +0.54 (p 0.137)receipt 2189
- PDZRN4 in oligodendrocytes, braak-0.46 (p 0.209) → +0.16 (p 0.689)receipt 2188
Swarm cases
receipt 2189: PDZRN4 in dopamine neurons, braak
- power
- full sample +0.34 (p 0.173, n 18), 95% CI -0.16 to +0.69. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.34 (p 0.173, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.33 (p 0.176, n 18). could be the mix.
- skeptic
- leave-one-out range +0.24 to +0.46, sign flips 0; without severely affected donors +0.34 (p 0.173, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for PDZRN4 in dopamine neurons.
case closed: nothing better to follow up.
receipt 2188: PDZRN4 in oligodendrocytes, braak
- power
- full sample -0.08 (p 0.767, n 18), 95% CI -0.52 to +0.41. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.01 (p 0.969, n 18). does not hold up.
- composition
- oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: -0.10 (p 0.683, n 18). could be the mix.
- skeptic
- leave-one-out range -0.21 to +0.03, sign flips 3; without severely affected donors -0.08 (p 0.767, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for PDZRN4 in oligodendrocytes.
case closed: nothing better to follow up.
Receipts
loading the receipts